(Q28283765)

https://doi.org/10.1023%2FB%3ADDAS.0000037803.32013.AA

25 March 2017

1 reference

Maurizio Ventrucci

1

1 reference

https://doi.org/10.1023%2FB%3ADDAS.0000037803.32013.AA

25 March 2017

Antonio Cipolla

2

1 reference

https://doi.org/10.1023%2FB%3ADDAS.0000037803.32013.AA

25 March 2017

Chiara Racchini

3

1 reference

https://doi.org/10.1023%2FB%3ADDAS.0000037803.32013.AA

25 March 2017

Riccardo Casadei

4

1 reference

https://doi.org/10.1023%2FB%3ADDAS.0000037803.32013.AA

25 March 2017

Patrizia Simoni

5

1 reference

https://doi.org/10.1023%2FB%3ADDAS.0000037803.32013.AA

25 March 2017

Lucio Gullo

6

1 reference

https://doi.org/10.1023%2FB%3ADDAS.0000037803.32013.AA

25 March 2017

language of work or name

English

0 references

publication date

August 2004

1 reference

https://doi.org/10.1023%2FB%3ADDAS.0000037803.32013.AA

Digestive Diseases and Sciences

25 March 2017

published in

1 reference

https://doi.org/10.1023%2FB%3ADDAS.0000037803.32013.AA

25 March 2017

volume

49

1 reference

https://doi.org/10.1023%2FB%3ADDAS.0000037803.32013.AA

25 March 2017

issue

7-8

0 references

7/8

1 reference

https://doi.org/10.1023%2FB%3ADDAS.0000037803.32013.AA

25 March 2017

page(s)

1149-55

0 references

1149-1155

1 reference

https://doi.org/10.1023%2FB%3ADDAS.0000037803.32013.AA

The pyruvate kinase isoenzyme tumor M2 (Tu M2-PK) as a tumor marker for renal carcinoma

25 March 2017

cites work

1 reference

12 December 2020

Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis

1 reference

12 December 2020

Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells.

1 reference

12 December 2020

Value of the serum levels of the tumor marker TUM2-PK in pancreatic cancer

1 reference

12 December 2020

Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK)

1 reference

12 December 2020

The tumor marker tumor M2-PK: an application in the diagnosis of gastrointestinal cancer.

1 reference

12 December 2020

Quantification of tumor type M2 pyruvate kinase (Tu M2-PK) in human carcinomas

1 reference

12 December 2020

The effects of injury and sepsis on fuel utilization

1 reference

12 December 2020

Tumor type M2 pyruvate kinase expression in advanced breast cancer

1 reference

12 December 2020

Quantitative detection of tumor M2-pyruvate kinase in plasma of patients with lung cancer in comparison to other lung diseases

1 reference

12 December 2020

Quantitative detection of tumor M2-PK in serum and plasma

1 reference

12 December 2020

Tumor M2-pyruvate kinase: a promising tumor marker in the diagnosis of gastro-intestinal cancer

1 reference

12 December 2020

CA 19-9 and CA 50 in benign and malignant pancreatic and biliary diseases

1 reference

12 December 2020

TUM2-PK (pyruvate kinase type tumor M2), CA19-9 and CEA in patients with benign, malignant and metastasizing pancreatic lesions

1 reference

12 December 2020

CA19-9: the Italian experience

1 reference

12 December 2020

Diagnostic value of tumor M2-pyruvate kinase in neuroendocrine tumors. A comparative study with chromogranin A.

1 reference

12 December 2020

Polytrauma induces increased expression of pyruvate kinase in neutrophils

1 reference

12 December 2020

Clinical utility of the serum CA 19-9 test for diagnosing pancreatic carcinoma in symptomatic patients: a prospective study

1 reference

12 December 2020

Pyruvate kinase and the interaction of amino acid and carbohydrate metabolism in solid tumors.

1 reference

12 December 2020

10.1023/B:DDAS.0000037803.32013.AA

Identifiers

DOI

1 reference

https://doi.org/10.1023%2FB%3ADDAS.0000037803.32013.AA